Griebs Darien Pharmacy Inc.
Community/Retail Pharmacy
1021 Post Rd, Darien
Connecticut, 06820-4510
203-655-1000 203-656-0172
Griebs Darien Pharmacy Inc. is an authorized DME supplier for medicare equipments and products.
Griebs Darien Pharmacy Inc. is a Community/Retail Pharmacy in Darien, Connecticut. It is located at 1021 Post Rd, Darien and it's customer support contact number is 203-655-1000. The authorized person of Griebs Darien Pharmacy Inc. is Debra Hibben who is Owner of the pharmacy and his contact number is 203-655-1000. Active license number of Griebs Darien Pharmacy Inc. is 118 for Community/Retail Pharmacy in Connecticut. Griebs Darien Pharmacy Inc. accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Griebs Darien Pharmacy Inc. is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Griebs Darien Pharmacy Inc. type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Griebs Darien Pharmacy Inc. |
| Type: | Community/Retail Pharmacy |
| Location: | 1021 Post Rd, Darien, Connecticut, 06820-4510 |
| Phone: | 203-655-1000 |
| Fax: | 203-656-0172 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Debra Hibben |
| Position: | Owner |
| Contact Number: | 203-655-1000 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1003926502 |
| NPI Enumeration Date: | 30 Aug, 2006 |
| NPI Last Update On: | 17 Oct, 2025 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Griebs Darien Pharmacy Inc. are as mentioned below.
| Specialization | License Number | State | Status | |
| Community/Retail Pharmacy | 118 | Connecticut | Primary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 940004026431 | Medicaid | Connecticut | |
Medicare Enrollment:
Griebs Darien Pharmacy Inc. is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 7810275351 | O20161103000716 | Griebs Darien Pharmacy Inc | PART B SUPPLIER - MASS IMMUNIZATION (ROSTER BILLER ONLY) |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1021 Post Rd, Darien, Connecticut |
| Zip: | 06820-4510 |
| Phone Number: | 203-655-1000 |
| Fax Number: | 203-656-0172 |
Patients can reach Griebs Darien Pharmacy Inc. at
1021 Post Rd, Darien, Connecticut or can
call on customer care at 203-655-1000.
Comments/ Reviews:
Read all the reviews posted for Griebs Darien Pharmacy Inc. below. You may also share your own experience with Griebs Darien Pharmacy Inc.. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.